Tag Archives: The Stem Cell Blog

Discovery’s ‘First In Human’ Calls Much-Needed Attention To Clinical Trials – Forbes

Continue reading

2017-08-17 NEWS

Forbes

Discovery’s ‘First In Human’ Calls Much-Needed Attention To Clinical Trials
Forbes
Cooper enrolled in a trial of a chimeric antigen receptor T cell (CAR-T) therapy, which involved removing T cells from his blood and engineering them to recognize and attack his cancer. This technology that has been in the spotlight lately, thanks to

and more »

Continue reading

2017-08-17 NEWS

Telegraph.co.uk

Gene therapy darling Oxford BioMedica pares losses
Telegraph.co.uk
A darling British biotech that is working on the development of the world’s leading gene therapy for cancer has posted reduced losses and a leap in sales. Oxford BioMedica signed a deal worth up to $100m (£77m) with Swiss drugs giant Novartis last

Continue reading

2017-08-17 NEWS

NormanObserver.com

Abeona Therapeutics to Host Gene Therapy R&D Day on October 11, 2017
Nasdaq
NEW YORK and CLEVELAND, Aug. 17, 2017 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, today …
Abeona Therapeutics Announces Pivotal Expansion Of Gene Therapy Trials In Sanfilippo Syndrome Type AClinical Leader
Abeona Therapeutics Inc. (ABEO) Releases Quarterly Earnings Results, Misses Expectations By $0.07 EPSStock Observer
What Next for Abeona Therapeutics Inc (ABEO) Stock After Today’s …Press Telegraph
Bloomberg
all 36 news articles »
Continue reading

2017-08-17 NEWS

Can Pfizer Bank on New Immunotherapy Bavencio for Growth?
Zacks.com
As demand for immuno-oncology drugs and their combinations rises, Pfizer, Inc.’s (PFE – Free Report) newly approved immunotherapy, Bavencio, is being considered a significant top-line driver for this New York-based pharma giant. Pfizer’s shares are up …

and more »

Continue reading

2017-08-17 NEWS

NormanObserver.com

Abeona Therapeutics Announces Pivotal Expansion Of Gene Therapy Trials In Sanfilippo Syndrome Type A
Clinical Leader
Abeona Therapeutics Inc., a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, recently announced the pivotal expansion of its gene therapy clinical trials for patients with
Abeona Therapeutics Announces Pivotal Expansion of ABO-102 Gene Therapy Clinical Trials in Sanfilippo Syndrome …London South East (registration) (blog)
Abeona Therapeutics Inc. (ABEO) Issues Earnings ResultsBNB Daily (blog)
What Next for Abeona Therapeutics Inc (ABEO) Stock After Today’s Big Increase?Press Telegraph
Transcript Daily –Herald KS
all 27 news articles »
Continue reading

2017-08-17 NEWS

Medical Xpress

Are stem cells the link between bacteria and cancer?
Medical Xpress
An interdisciplinary research team at the Max Planck Institute in Berlin in collaboration with researchers in Stanford, California, has now discovered that the bacterium sends stem cell renewal in the stomach into overdrive – and stem cell turnover has